Part Of Apriso Patent Nixed In IPR With Hedge Fund Ties
The Patent Trial and Appeal Board on Friday invalidated part of a patent covering Apriso, an ulcerative colitis treatment, in an inter partes review that included generic drugmakers and a hedge...To view the full article, register now.
Already a subscriber? Click here to view full article